Latest News

Ultragenyx Pharmaceutical Inc. (RARE) Discusses FDA Approval of FAYUVI as First Treatment for Sanfilippo Syndrome Type A Transcript

With U.S. stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:

Saudi rerouting eases immediate oil supply fears, but Hormuz restrictions persist as WTI tests $95.42, Brent weakens and LNG markets stay tight.

William Chalmers, chief financial officer of Lloyds Banking Group NYSE: LYG, said the lender's Accelerate 2030 strategy is designed to build on progress under its prior plan through customer-experienc

U.S. stock futures are posting slight gains early Friday as investors digest targeted geopolitical sanctions, debates over Federal Reserve independence, and the Bank of Japan's 31-year high rate-hike

Zoetis NYSE: ZTS executives said the company remains confident in its previously issued guidance despite pressure in the U.S. companion-animal market, citing a weaker pet-care environment and intensif

Mercury NZ Limited (MGHTF) Shareholder/Analyst Call Transcript

Aruma Resources Ltd (ASX:AAJ) will host an investor webinar next week to discuss its ongoing Phase 2 diamond drilling program at the Tillex Copper-Silver Project in Ontario, Canada, following the rele

AeroVironment is transforming from a tactical drone maker into a full-spectrum defense technology platform, integrating autonomy, software, and counter-UAS capabilities. Despite a $265M GAAP net loss

Reserve Bank of Australia governor Michele Bullock has warned that upside risks to inflation are beginning to materialise, raising the prospect that interest rates may need to rise again despite signs

Rocket Companies NYSE: RKT President and Chief Financial Officer Brian Brown said the company sees opportunities to gain mortgage market share despite pressure from elevated interest rates, citing its

Claude now leads 26% of Anthropic's AI R&D work, up from 1% in March. Anthropic said that humans still supervise Claude and that it is not fully autonomous.

Dyno Nobel Limited (DNLZY) Analyst/Investor Day Transcript

Wacker Chemie AG (WKCMF) Analyst/Investor Day Transcript

Alibaba is upgraded to Strong Buy after a 16% correction post-Q1 earnings miss, with forward P/E compressed to 16.5x, which seems overdone. AI Cloud revenue surged 45% YoY; maintaining over 40% and an

Upexi, Inc. (UPXI) Q4 2026 Earnings Call Transcript

Omega Healthcare remains Buy rated, offering a near 6% yield and structural advantages in skilled nursing real estate. OHI's upcoming earnings are expected to be quietly strong, with AFFO/share modele

My mentor always told me never to speculate on rates, but today I'm looking at TLT with interest. Current 20-year yields around 5.3% look elevated relative to Fed inflation and neutral rate projection

SAN DIEGO, Sept. 17, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company"), today announced the pricing of $1.3 billion aggregate principal amount of 1.50% conv

Vermilion Energy remains a Strong Buy, trading at a deep discount amid its ongoing portfolio transformation. VET is nearing a major cash flow inflection, with Montney and European projects ramping, ta